BIND Therapeutics' Series C - II Round

BIND Therapeutics raised a round of funding on June 12, 2010.

BIND Therapeutics, formerly BIND Biosciences, is a biopharmaceutical company leveraging its Medicinal Nanoengineering platform to design, engineer and manufacture targeted therapeutics. Medicinal Nano…

Articles about BIND Therapeutics' Series C - II Round: